Indeed, recent reports have shown that IL-17A plays a role in skin wound healing (18) and gut epithelial repair (19) while αIL-17A and αIFNγ mAbs have been developed to treat psoriasis (20) and lymphohistiocytosis (21), respectively, in humans, with favorable outcomes. The gene discussed is IL17A; the disease is psoriasis.